startups

As China builds biotech sector, cash floods U.S. startups
As China builds biotech sector, cash floods U.S. startups
Yahoo/Reuters
China
biotech
startups
Flag link:
Amgen Offering Golden Ticket for Biotech Startups
Amgen Offering Golden Ticket for Biotech Startups
BioSpace
Amgen
biotech
startups
Flag link:
Four Healthcare Startups Raised Over $130 Million Last Month
Four Healthcare Startups Raised Over $130 Million Last Month
Forbes
startups
23andMe
Gossamer Bio
Alector
Compass Therapeutics
Flag link:
The Google of CRISPR tech? Tech legends Tim Cook and Jeff Huber back Mammoth Biosciences
The Google of CRISPR tech? Tech legends Tim Cook and Jeff Huber back Mammoth Biosciences
Endpoints
CRISPR
startups
Mammoth Biosciences
Flag link:
How this Founder Bootstrapped a Profitable SaaS Product for Dentists in Under Three Years
How this Founder Bootstrapped a Profitable SaaS Product for Dentists in Under Three Years
Forbes
SaaS
Auxpanel
dentistry
entrepreneurship
startups
Flag link:
As biotech funds sprout around the globe, Sanofi and government bank are setting up a $292M operation in France
As biotech funds sprout around the globe, Sanofi and government bank are setting up a $292M operation in France
Endpoints
France
biotech
startups
venture funds
venture capital
Flag link:
Theranos? Whatever. Healthcare Startups Have Raised $15 Billion So Far This Year
Theranos? Whatever. Healthcare Startups Have Raised $15 Billion So Far This Year
Forbes
startups
Theranos
Flag link:
NYC’s biotech scene gets cash and office space with Beacon’s new incubator
NYC’s biotech scene gets cash and office space with Beacon’s new incubator
Endpoints
NYC
biotech
Beacon Pharma
startups
Flag link:
Anti-Aging Startup Unity Bio Grabs $55M, Plans First Clinical Trial
Anti-Aging Startup Unity Bio Grabs $55M, Plans First Clinical Trial
Xconomy
startups
anti-aging
Unity Biotechnology
Flag link:
In Two Months, Biotech Startups Raised More Money Than In All Of 2013
In Two Months, Biotech Startups Raised More Money Than In All Of 2013
Forbes
biotech
startups
venture capital
Flag link:
Quentis Nets $48M For Cancer Drugs, Building Buzz For NY Bio Startups
Quentis Nets $48M For Cancer Drugs, Building Buzz For NY Bio Startups
Xconomy
Quentis
biotech
startups
cancer
NYC
Flag link:
4 Positive Changes Happening in Pharmaceutical Sales in 2018
4 Positive Changes Happening in Pharmaceutical Sales in 2018
Medreps.com
pharma sales
minorities
startups
artificial intelligence
Flag link:
Venturing Boldly Into Neuroscience
Venturing Boldly Into Neuroscience
Forbes
startups
Neuroscience
Disarm Therapeutics
Rodin Therapeutics
Lysosomal Therapeutics
Flag link:
Big names, big companies back a cell therapy startup run by a high-profile regenerative med expert
Big names, big companies back a cell therapy startup run by a high-profile regenerative med expert
Endpoints
cell therapy
startups
regenerative medicine
Celgene
Hariri
R&D
Flag link:
Biotech Wunderkind Raises $1.1 Billion To Fund Pharma Startups
Biotech Wunderkind Raises $1.1 Billion To Fund Pharma Startups
Forbes
startups
biotech
Roivant
Vivek Ramaswamy
Flag link:
Five Questions for … Austin Biotech Entrepreneur Laura Bosworth
Five Questions for … Austin Biotech Entrepreneur Laura Bosworth
Xconomy
Laura Bosworth
3D printing
startups
TeVido BioDevices
devices
Flag link:
‘Instagram for docs’ startup Figure 1 raises $10m
‘Instagram for docs’ startup Figure 1 raises $10m
Mass Device
social media
physicians
startups
Flag link:
After a bruising turn as Sarepta CEO, Chris Garabedian is back in biotech with a new role as godfather to a bunch of startups
After a bruising turn as Sarepta CEO, Chris Garabedian is back in biotech with a new role as godfather to a bunch of startups
Endpoints
Sarepta Therapeutics
Chris Garabedian
Xontogeny
startups
Flag link:
The 10 hottest medtech startups of 2017
The 10 hottest medtech startups of 2017
Mass Device
devices
startups
Basil Leaf Technologies
BioLert
Catalia Health
Frequency Therapeutics
Green Sun Medical
Ivenix
Madorra
NeuSpera Medical
Onkos Surgical
Renova Care
Flag link:
Backed by a biotech legend, two young entrepreneurs tackle one of the Holy Grails of R&D
Backed by a biotech legend, two young entrepreneurs tackle one of the Holy Grails of R&D
Endpoints
R&D
startups
ALS
Lou Gehrig's disease
Amylyx
Henri Termeer
Flag link:

Pages